Clinical Trial Update: Cannabidiol to Reduce Anxiety Reactivity [Phase 2]

View source ↗

Summary

This report indicates the completion of a Phase 2 clinical trial evaluating cannabidiol (CBD) for reducing anxiety reactivity in adults with social anxiety diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of California, San Diego | Conditions: Social Anxiety, Social Anxiety Disorder | Phase 2 | Status: COMPLETED